0 Commentaires
0 Parts
60 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Long-Acting Injectable Oncology Drug Market Segmentation & Forecast, Share, SizeFuture of Executive Summary Long-Acting Injectable Oncology Drug Market Market: Size and Share Dynamics The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period. A DBMR team of experts and professionals from a number of...0 Commentaires 0 Parts 272 Vue 0 Aperçu
-
Long-Acting Injectable Oncology Drug Market Size, Share, Segments and TrendExecutive Summary Long-Acting Injectable Oncology Drug Market Growth Trends and Share Breakdown The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period. This global Long-Acting Injectable Oncology Drug Market...0 Commentaires 0 Parts 57 Vue 0 Aperçu
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commentaires 0 Parts 99 Vue 0 Aperçu
-
Emerging Therapies Transforming the Sarcoma Drugs IndustryImmunotherapy is emerging as a promising treatment approach.Checkpoint inhibitors are being evaluated for sarcoma cases.Combination therapies are improving patient survival outcomes. The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...0 Commentaires 0 Parts 781 Vue 0 Aperçu
-
Future of Radiation Protection: Anti-Radiation Drugs Market InsightsThe market is gaining traction as cancer treatment protocols increasingly incorporate radiation therapy. The need to reduce therapy-related toxicity is boosting adoption of anti-radiation drugs. Continuous innovation is expanding therapeutic applications. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...0 Commentaires 0 Parts 469 Vue 0 Aperçu
-
Global Bladder Cancer Market Trends Shaping Treatment FutureThe rising aging population remains a key growth factor for the market.Older adults face higher risks of bladder cancer, increasing treatment demand.Healthcare systems are responding with improved therapeutic and diagnostic infrastructure. 5. The Bladder Cancer Therapeutics and Diagnostics Market is projected to register a robust CAGR of 10.2% from 2025 to 2031, with market size expanding...0 Commentaires 0 Parts 680 Vue 0 Aperçu
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Commentaires 0 Parts 20 Vue 0 Aperçu
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Commentaires 0 Parts 184 Vue 0 Aperçu
-
Rising Demand for Precision Oncology Boosting Sarcoma Drugs Market GrowthAdvancements in precision medicine are positively influencing the Sarcoma Drugs Market. Personalized therapies are helping physicians deliver more effective treatments for sarcoma patients. This approach is expected to drive significant market growth over the forecast period. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from...0 Commentaires 0 Parts 709 Vue 0 Aperçu
-
Unpacking Oncology Small Molecule Drugs Market Growth, Opportunities, Drivers, Strategies, Trends, and Forecast to 2031The Oncology Small Molecule Drugs Market is experiencing significant evolution as stakeholders across the pharmaceutical and biotechnology landscape intensify innovation efforts to address the growing global cancer burden. According to the Oncology Small Molecule Drugs Market report by The Insight Partners, the market is projected to grow at a compound annual growth rate (CAGR) of 5.6% from...0 Commentaires 0 Parts 259 Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
